Clinical trials are crucial to the development of new drugs, medical treatments, and therapeutics. The knowledge gained from these trials helps ensure that treatments are safe and effective. Trials are also sometimes the only way for patients to access the most cutting-edge therapies for a disease. However, wide swaths of the American population, including Black and Latino Americans who often face the greatest health challenges, are not adequately represented in the clinical trials and do not benefit equitably from this research.

In this episode, host Sara Frueh is joined by Gloria Coronado, an epidemiologist with the Kaiser Permanente Center for Health Research, and Jason Resendez, president of the National Alliance for Caregiving, to discuss the causes and consequences of this underrepresentation, and steps researchers and policymakers should take to remedy it.

Resources:

• Read the May 2022 consensus report from the National Academies, Improving Representation in Clinical Trials and Research: Building Equity for Women and Underrepresented Groups.